Abstract: A method and system for myocardial information determination may be provided. Medical images of the heart of a target subject may be obtained. The medical images may be collected by performing a medical scan on the target subject when the target subject is injected with a first tracer. A target model that has been trained using training samples may be obtained. Each training sample includes label information collected using a second tracer. Blood flow information and/or cardiac function information of the heart of the target subject may be determined based on the medical images and the target model.

Abstract: The present application provides a compound in formula III, and further provides a use of the compound in the synthesis of a Brivaracetam intermediate and a crude drug, and a synthesis method. A raw material involved in the method of the present application is low in costs and easily available; (R)-4-propyl-dihydrofuran-2-ketone having high optical purity can be prepared; complicated separation and purification steps are avoided; costs are reduced, and the method is more applicable to industrial production.

Abstract: The present application provides a compound in formula III, and further provides a use of the compound in the synthesis of a Brivaracetam intermediate and a crude drug, and a synthesis method. A raw material involved in the method of the present application is low in costs and easily available; (R)-4-propyl-dihydrofuran-2-ketone having high optical purity can be prepared; complicated separation and purification steps are avoided; costs are reduced, and the method is more applicable to industrial production.